Company / CapEx per Share
RAPT Therapeutics, Inc. CapEx per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.03
FY2020-FY2024
Trend
-89.8%
vs FY2023
Sector context
#153 of 191
Health Care
What the data says
RAPT Therapeutics, Inc.'s capex per share of $0.00 is lower than 80% of companies in the Health Care sector (FY2024). CapEx per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2024 to $5.62 in FY2018.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -57.0%.
Declined from $0.03 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -52.3%
- 5-Year CAGR
- -57.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 191This company $0.00 Sector average $4.05
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 89.8% year-over-year.
- Ranks #153 out of 191 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -89.8% |
| FY2023 | $0.03 | +13.0% |
| FY2022 | $0.03 | -5.8% |
| FY2021 | $0.03 | +67.1% |
| FY2020 | $0.02 | -91.9% |
| FY2019 | $0.20 | -96.4% |
| FY2018 | $5.62 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026